BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

  March 13, 2025

   · 

  11 min read
• Press Releases

  Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

  March 13, 2025

   · 

  15 min read
• Press Releases

  Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

  March 13, 2025

   · 

  10 min read
• Press Releases

  Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

  March 13, 2025

   · 

  4 min read
• Press Releases

  NKGen Biotech To Present on Potential of Troculeucel for the Treatment of Neurodegenerative Diseases at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit

  March 13, 2025

   · 

  5 min read
• Press Releases

  Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

  March 13, 2025

   · 

  14 min read
• Press Releases

  Perfuze Receives FDA 510(k) Clearance for Zipline™ Access Catheters and Secures €22M in Additional Funding

  March 13, 2025

   · 

  3 min read
• Press Releases

  RadNet, Inc. to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference March 17th, 2025

  March 13, 2025

   · 

  1 min read
• Press Releases

  Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

  March 13, 2025

   · 

  3 min read
• Press Releases

  Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update

  March 13, 2025

   · 

  11 min read